The Endovascular Coronary Sinus Catheter in Minimally Invasive Mitral and Tricuspid Valve Surgery: A Case Series
published online 20 July 2010. Corrected Proof
Objectives
To determine the safety and efficacy of a standardized approach to the use of an endovascular coronary sinus (CS) catheter during minimally invasive cardiac surgery.
Design
Case series.
Setting
University hospital.
Participants
Patients undergoing mitral and/or tricuspid valve surgery using a minimally invasive cardiac surgery approach.
Interventions
An endovascular CS catheter was placed to enable the administration of retrograde cardioplegia using transesophageal echocardiography (TEE), fluoroscopy, and CS pressure measurements.
Measurements and Main Results
Data were collected from 96 patient records. A total of 95 (99.0%) endovascular coronary sinus catheters were positioned. The mean time to insert the catheter into the sinus ostium under TEE guidance was 6.3 ± 8.4 minutes. Confirmation of adequate positioning with fluoroscopy took an average of 9.1 ± 10.6 minutes for a mean total procedure time of 16.1 ± 14.1 minutes. Successful positioning, as defined by the ability to generate a perfusion pressure in the CS greater than 30 mmHg during surgery, was achieved in 87.5% of cases. During positioning, ventricularization of the CS pressure curve was observed in 86.0% of cases. The presence of ventricularization was associated with an increase in positioning success (odds ratio = 15.8; 95% confidence interval, 3.713-67.239). One patient developed extravasation of contrast agent after CS catheter placement, without evidence of CS rupture.
Conclusions
Endovascular CS catheter insertion can be performed with a high rate of success for positioning and a low complication rate. During positioning, obtaining ventricularization is associated with an increased success rate.
⁎Department of Anesthesiology, Montreal Heart Institute, Montreal, Quebec, Canada
†Department of Perfusion, Montreal Heart Institute, Montreal, Quebec, Canada
‡Department of Respiratory Therapy, Montreal Heart Institute, Montreal, Quebec, Canada
§Department of Cardiac Surgery, Montreal Heart Institute, Montreal, Quebec, Canada
¶Montreal Heart Institute Coordinating Center, Montreal, Quebec, Canada
Address reprint requests to Jean-Sébastien Lebon, BPharm, MD, FRCPC, Department of Anesthesiology, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec H1T1C8, Canada
ABSTRACT